300942 Shenzhen Bioeasy Biotechnology
- 8.94
- 0.000.00%
Shenzhen Bioeasy Biotechnology News
E-Rui Biotech: Announcement on convertible debt-for-equity swaps in the third quarter of 2024
Yirui Biology: Dongxing Securities Co., Ltd.\'s first temporary fiduciary management report on the issuance of convertible corporate bonds by Shenzhen Yirui Biotechnology Co., Ltd. to unspecified targets in 2024
Yirui Biotech: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
E-Rui Biotech: Announcement on the downward revision of the “E-Rui Bonds” conversion price
Yi Rui Biology: Legal Opinion of Guohao Attorney (Shenzhen) Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Shenzhen Yirui Biotechnology Co., Ltd.
Yi Rui Biotech: Announcement on the Change of Continued Supervisory Sponsor Representative
Yirui Biotech: Announcement on the change of office address and investor hotline number
Yirui Biotech: Summary table of non-operating capital occupation and other related capital transactions for the first half year of 2024
Yirui Biotech: Notice on Convening the Company\'s Third Extraordinary General Meeting of Shareholders in 2024
Yirui Biotech: Announcement on the Use of Some Idle Funds Raised and Own Funds for Cash Management
E-Rui Biotech: Announcement on the Board\'s Proposal to Lower the Exchange Price of “E-Rui Bonds”
Shenzhen Bioeasy Biotechnology: Notice of the Expected Downward Revision of Conversion Price Triggers for "Yirui Convertible Bonds"
Shenzhen Bioeasy Biotechnology: Announcement on the progress of cooperating with professional investment institutions for investment.
Shenzhen Bioeasy Biotechnology: Announcement regarding the interest payment of the Yirui Convertible Bonds in 2024.
Shenzhen Bioeasy Biotechnology: Announcement regarding the debt-for-equity swaps in the second quarter of 2024 for convertible bonds.
Shenzhen Bioeasy Biotechnology: 2023 Shenzhen Yirui Biotechnology Co., Ltd. Growth issued convertible bonds to unspecified parties on the ChiNext, and the 2024 tracking rating report.
Shenzhen Bioeasy Biotechnology: CSI Enterprise Bond Index issued convertible bonds to unspecified recipients, entrusted management affairs report (2023).
Shenzhen Bioeasy Biotechnology: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Shenzhen Bioeasy Biotechnology: Legal Opinion on the Second Extraordinary Shareholders' Meeting of Shenzhen Yirui Biotechnology Co., Ltd. in 2024 by Guohao Law Firm (Shenzhen)
Shenzhen Bioeasy Biotechnology: Notice on convening the company's second extraordinary general meeting of shareholders in 2024
Analysis
Price Target
No Data
No Data